Comparing Aspirin, Warfarin, and Rivaroxaban for Preventing Venous Thromboembolism After Hip or Knee Replacement
A large noninferiority trial comparing aspirin, warfarin, and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty found no definitive superiority among agents for efficacy or safety at six months.
















